Therapeutic genome editing by combined viral and non-viral delivery of CRISPR system components in vivo

Yin, Hao, Song, Chun-Qing, Dorkin, Joseph R, Zhu, Lihua J, Li, Yingxiang, Wu, Qiongqiong, Park, Angela, Yang, Junghoon +14 more·2016·Nature Biotechnology
DOI 10.1038/nbt.3471

Cited by (874)

Items 301–400 of 874

  1. A potential paradigm in CRISPR/Cas systems delivery: at the crossroad of microalgal gene editing and algal-mediated nanoparticles
    Shuying Feng, Xin Xie, Junjie Liu, Aifang Li, Qianqian Wang, Dandan Guo, Shuxuan Li, Yalan Li, Zilong Wang, Tao Guo et al. · 2023 · Journal of Nanobiotechnology
  2. Lipid Nanoparticles for Delivery of CRISPR Gene Editing Components
    Fan Wu, Nei Li, Yi Xiao, Rohan Palanki, Hannah M. Yamagata, Michael J. Mitchell, Xuexiang Han · 2025 · Small Methods
  3. Development and applications of mRNA treatment based on lipid nanoparticles
    Zhe Wang, Wanting Ma, Xingxing Fu, Yanfei Qi, Yinan Zhao, Shubiao Zhang · 2023 · Biotechnology Advances
  4. Nano-bio interactions in mRNA nanomedicine: Challenges and opportunities for targeted mRNA delivery
    Qimanguli Saiding, Zhongyang Zhang, Shuying Chen, Fan Xiao, Yumeng Chen, Yongjiang Li, Xueyan Zhen, Muhammad Muzamil Khan, Wei Chen, Seyoung Koo et al. · 2023 · Advanced Drug Delivery Reviews
  5. Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9
    Calvin J. Stephens, Elena A. Kashentseva, William Everett, Lyudmila N. Kaliberova, David T. Curiel · 2018 · Gene Therapy
  6. CRISPR-Cas9 Gene Therapy: Non-Viral Delivery and Stimuli-Responsive Nanoformulations
    Hyunwoo Lee, Won‐Yeop Rho, Yoon-Hee Kim, Hyejin Chang, Bong‐Hyun Jun · 2025 · Molecules
  7. A CRISPR Path to Engineering New Genetic Mouse Models for Cardiovascular Research
    Joseph M. Miano, Qiuyu Martin Zhu, Charles J. Lowenstein · 2016 · Arteriosclerosis Thrombosis and Vascular Biology
  8. CRISPR-Based Tools in Immunity
    Dimitre R. Simeonov, Alexander Marson · 2019 · Annual Review of Immunology
  9. CCR5 editing by Staphylococcus aureus Cas9 in human primary CD4+ T cells and hematopoietic stem/progenitor cells promotes HIV-1 resistance and CD4+ T cell enrichment in humanized mice
    Qiaoqiao Xiao, Shuliang Chen, Qiankun Wang, Zhepeng Liu, Shuai Liu, Huan Deng, Wei Hou, Dongcheng Wu, Yong Xiong, Jiafu Li et al. · 2019 · Retrovirology
  10. Angiopoietin-Like 3
    Xiao Wang, Kiran Musunuru · 2019 · JACC Basic to Translational Science
  11. In vivo delivery of CRISPR-Cas9 genome editing components for therapeutic applications
    Kun Lun Huang, Daniel A. Zapata, Yan Tang, Yong Teng, Yamin Li · 2022 · Biomaterials
  12. The Hope and Hype of CRISPR-Cas9 Genome Editing
    Kiran Musunuru · 2017 · JAMA Cardiology
  13. Retracted: Applications and advances of CRISPR-Cas9 in cancer immunotherapy
    Anliang Xia, Qifeng He, Jincheng Wang, Jing Zhu, Yeqin Sha, Beicheng Sun, Xiaojie Lu · 2018 · Journal of Medical Genetics · Retracted
  14. Advances in gene therapy for hemophilia: basis, current status, and future perspectives
    Tsukasa Ohmori · 2018 · International Journal of Hematology
  15. CRISPR-cas9 genome editing delivery systems for targeted cancer therapy
    Asma Ghaemi, Elnaz Bagheri, Khalil Abnous, Seyed Mohammad Taghdisi, Mohammad Ramezani, Mona Alibolandi · 2020 · Life Sciences
  16. Genome-wide detection of CRISPR editing in vivo using GUIDE-tag
    Liang, Shun-Qing, Liu, Pengpeng, Smith, Jordan L., Mintzer, Esther, Maitland, Stacy, Dong, Xiaolong, Yang, Qiyuan, Lee, Jonathan, Haynes, Cole M., Zhu, Lihua Julie et al. · 2022 · Nature Communications
  17. Intelligent nanotherapeutic strategies for the delivery of CRISPR system
    Chao Chen, Wu Zhong, Shiyu Du, Yayao Li, Yunfei Zeng, Kunguo Liu, Jingjing Yang, Xiaoxiang Guan, Xin Han · 2022 · Acta Pharmaceutica Sinica B
  18. More than a delivery system: the evolving role of lipid-based nanoparticles
    Senjuti Karmaker, Plinio D. Rosales, Barath Tirumuruhan, Amartya Viravalli, Natalie Boehnke · 2025 · Nanoscale
  19. Genome editing for inborn errors of metabolism: advancing towards the clinic
    Jessica L. Schneller, Ciaran M. Lee, Gang Bao, Charles P. Venditti · 2017 · BMC Medicine
  20. Therapeutic applications of CRISPR/Cas9 system in gene therapy
    Hasan Mollanoori, Shahram Teimourian · 2018 · Biotechnology Letters
  21. Efficient drug and gene delivery to liver fibrosis: rationale, recent advances, and perspectives
    Somayeh Mahdinloo, Seyed Hossein Kiaie, Ala Amiri, Salar Hemmati, Hadi Valizadeh, Parvin Zakeri‐Milani · 2020 · Acta Pharmaceutica Sinica B
  22. Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors
    Karim E. Shalaby, Mustapha Aouida, Omar M. A. El‐Agnaf · 2020 · International Journal of Molecular Sciences
  23. CRISPR: History and perspectives to the future
    Zuzana Kozovská, S. Rajcaniova, P. Munteanu, S. Dzacovska, Lucia Demková · 2021 · Biomedicine & Pharmacotherapy
  24. Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning
    Luo, Jie, Molbay, Muge, Chen, Ying, Horvath, Izabela, Kadletz, Karoline, Kick, Benjamin, Zhao, Shan, Al-Maskari, Rami, Singh, Inderjeet, Ali, Mayar et al. · 2025 · Nature Biotechnology
  25. Advance trends in targeting homology-directed repair for accurate gene editing: An inclusive review of small molecules and modified CRISPR-Cas9 systems
    Forough Shams, Hadi Bayat, Omid Mohammadian, Somayeh Mahboudi, Hassan Vahidnezhad, Mohsen Soosanabadi, Azam Rahimpour · 2022 · Bioimpacts
  26. Endothelial cell calpain as a critical modulator of angiogenesis
    Yixuan Zhang, Norika Mengchia Liu, Yongchen Wang, Ji Youn Youn, Hua “Linda” Cai · 2017 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  27. Non-viral and viral delivery systems for CRISPR-Cas9 technology in the biomedical field
    Zhiyao He, Ke Men, Zhou Qin, Yang Yang, Ting Xu, Yu-Quan Wei · 2017 · Science China Life Sciences
  28. Gene correction of HBB mutations in CD34+ hematopoietic stem cells using Cas9 mRNA and ssODN donors
    Justin S. Antony, Ngadhnjim Latifi, A.K.M. Ashiqul Haque, Andrés Lamsfus‐Calle, Alberto Daniel-Moreno, Sebastian Graeter, Praveen Baskaran, Petra Weinmann, Markus Mezger, Rupert Handgretinger et al. · 2018 · Molecular and Cellular Pediatrics
  29. CRISPR/Cas9 for cancer treatment: technology, clinical applications and challenges
    Xing Cheng, Shaoyi Fan, Chengcai Wen, Xianfa Du · 2020 · Briefings in Functional Genomics
  30. Approach for in vivo delivery of CRISPR/Cas system: a recent update and future prospect
    Yu-Fan Chuang, Andrew J. Phipps, Fan‐Li Lin, Valerie F G Hecht, Alex William Hewitt, Peng‐Yuan Wang, Guei‐Sheung Liu · 2021 · Cellular and Molecular Life Sciences
  31. Prospects and challenges of CRISPR/Cas genome editing for the study and control of neglected vector‐borne nematode diseases
    Mostafa Zamanian, Erik C. Andersen · 2016 · FEBS Journal
  32. Applications of Genome Editing Technology in Animal Disease Modeling and Gene Therapy
    Qian Li, Zhou Qin, Qingnan Wang, Ting Xu, Yang Yang, Zhiyao He · 2019 · Computational and Structural Biotechnology Journal
  33. Mesenchymal stem cell derived extracellular vesicles for repairing the neurovascular unit after ischemic stroke
    Davis, Courtney, Savitz, Sean I., Satani, Nikunj · 2021 · Cells
  34. CRISPR/Cas9 Inhibits Multiple Steps of HIV-1 Infection
    Lijuan Yin, Siqi Hu, Shan Mei, Hong Sun, Fengwen Xu, Jian Li, Weijun Zhu, Xiaoman Liu, Fei Zhao, Di Zhang et al. · 2018 · Human Gene Therapy
  35. Stearyl polyethylenimine complexed with plasmids as the core of human serum albumin nanoparticles noncovalently bound to CRISPR/Cas9 plasmids or siRNA for disrupting or silencing PD-L1 expression for immunotherapy
    Wei-Jie Cheng, Ling-Chun Chen, Hsiu‐O Ho, Hong-Liang Lin, Ming‐Thau Sheu · 2018 · International Journal of Nanomedicine
  36. In Vivo Editing of Macrophages through Systemic Delivery of CRISPR‐Cas9‐Ribonucleoprotein‐Nanoparticle Nanoassemblies
    Yi‐Wei Lee, Rubul Mout, David C. Luther, Yuanchang Liu, Laura J. Castellanos-García, Amy Burnside, Moumita Ray, Gülen Yesilbag Tonga, Joseph Michael Hardie, Harini Nagaraj et al. · 2019 · Advanced Therapeutics
  37. Nucleic acid nanostructure for delivery of CRISPR/Cas9‐based gene editing system
    Wantao Tang, Jianbing Liu, Baoquan Ding · 2022 · Interdisciplinary medicine
  38. Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations
    Shreya Bhattacharya, Priyadarshi Satpati · 2022 · ACS Omega
  39. In the business of base editors: Evolution from bench to bedside
    Elizabeth M. Porto, Alexis C. Komor · 2023 · PLoS Biology
  40. CRISPR: a versatile tool for both forward and reverse genetics research
    Channabasavaiah B. Gurumurthy, M’hamed Grati, Masato Ohtsuka, Samantha L.P. Schilit, Rolen M. Quadros, Xue Zhong Liu · 2016 · Human Genetics
  41. Specific targeting of point mutations in EGFR L858R-positive lung cancer by CRISPR/Cas9
    Alvin H.K. Cheung, Chit Chow, Jinglin Zhang, Yuhang Zhou, Tingting Huang, Kayla Ching-Kei Ng, Terry C. T. Or, Yoyo Yao Yao, Yujuan Dong, Jackie Mei-Wah Fung et al. · 2018 · Laboratory Investigation
  42. On-chip multiplexed single-cell patterning and controllable intracellular delivery
    Zaizai Dong, Yanli Jiao, Bingteng Xie, Yongcun Hao, Pan Wang, Yuanyuan Liu, Junfeng Shi, Chandani Chitrakar, Stephen M. Black, Yu-Chieh Wang et al. · 2020 · Microsystems & Nanoengineering
  43. Modern therapeutic approaches to liver-related disorders
    Antoine Gardin, Katharina Remih, Emmanuel M. Gonzales, Emma Rachel Andersson, Pavel Strnad · 2022 · Journal of Hepatology
  44. Stimulus-Responsive Smart Nanoparticles-Based CRISPR-Cas Delivery for Therapeutic Genome Editing
    Muhammad Naeem, Mubasher Zahir Hoque, Muhammad Ovais, Chanbasha Basheer, Irshad Ahmad · 2021 · International Journal of Molecular Sciences
  45. Enhancing CRISPR/Cas systems with nanotechnology
    Rupali Chowdhry, Steven Z. Lu, Seungheon Lee, Shivudu Godhulayyagari, Sasha B. Ebrahimi, Devleena Samanta · 2023 · Trends in biotechnology
  46. Future of rAAV Gene Therapy: Platform for RNAi, Gene Editing, and Beyond
    Paul N. Valdmanis, Mark A. Kay · 2017 · Human Gene Therapy
  47. Cas9 Ribonucleoprotein Delivery via Microfluidic Cell‐Deformation Chip for Human T‐Cell Genome Editing and Immunotherapy
    Xin Han, Zongbin Liu, Yuan Ma, Kai Zhang, Lidong Qin · 2017 · Advanced Biosystems
  48. Strategies for the CRISPR-Based Therapeutics
    Bin Li, Yuyu Niu, Weizhi Ji, Yizhou Dong · 2019 · Trends in Pharmacological Sciences
  49. Targeted Genome Replacement via Homology-directed Repair in Non-dividing Cardiomyocytes
    Takamaru Ishizu, Shuichiro Higo, Yuki Masumura, Yasuaki Kohama, Mikio Shiba, Tomoaki Higo, Masato Shibamoto, Akito Nakagawa, Sachio Morimoto, Seiji Takashima et al. · 2017 · Scientific Reports
  50. Use of CRISPR/Cas9 gene-editing tools for developing models in drug discovery
    Gulzar Ahmad, Mansoor M. Amiji · 2018 · Drug Discovery Today
  51. Synthesis and Evaluation of pH-Sensitive Multifunctional Lipids for Efficient Delivery of CRISPR/Cas9 in Gene Editing
    Da Sun, Zhanhu Sun, Hongfa Jiang, Amita M. Vaidya, Rui Xin, Nadia R. Ayat, Andrew L. Schilb, Peter L. Qiao, Zheng Han, Amirreza Naderi et al. · 2018 · Bioconjugate Chemistry
  52. The Future of In Utero Gene Therapy
    Peranteau, William H., Flake, Alan W. · 2020 · Molecular Diagnosis & Therapy
  53. Treatment of monogenic and digenic dominant genetic hearing loss by CRISPR-Cas9 ribonucleoprotein delivery in vivo
    Yong Tao, Verónica Lamas, Wan Du, Wenliang Zhu, Yiran Li, Madelynn N. Whittaker, John A. Zuris, David B. Thompson, Arun Prabhu Rameshbabu, Yilai Shu et al. · 2023 · Nature Communications
  54. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management
    Khaled S. Allemailem, Mohammed A. Alsahli, Ahmad Almatroudi, Faris Alrumaihi, Waleed Al Abdulmonem, Amira A. Moawad, Wanian M Alwanian, Nahlah Makki Almansour, Arshad Husain Rahmani, Amjad Ali Khan · 2023 · International Journal of Nanomedicine
  55. A universal system to select gene-modified hepatocytes in vivo
    Sean C. Nygaard, Adi Barzel, Annelise Haft, Angela M. Major, Milton J. Finegold, Mark A. Kay, Markus Grompe · 2016 · Science Translational Medicine
  56. Homology-based repair induced by CRISPR-Cas nucleases in mammalian embryo genome editing
    Xiya Zhang, Tao Li, Jianping Ou, Junjiu Huang, Puping Liang · 2021 · Protein & Cell
  57. A Nucleic Acid/Gold Nanorod-Based Nanoplatform for Targeted Gene Editing and Combined Tumor Therapy
    Wantao Tang, Lin Han, Xuehe Lu, Zhaoran Wang, Fengsong Liu, Yan Li, Shengbo Liu, Shaoli Liu, Run Tian, Jianbing Liu et al. · 2021 · ACS Applied Materials & Interfaces
  58. Gene Editing and Genetic Lung Disease. Basic Research Meets Therapeutic Application
    Deepthi Alapati, Edward E. Morrisey · 2016 · American Journal of Respiratory Cell and Molecular Biology
  59. Lipid-based nanocarrier mediated CRISPR/Cas9 delivery for cancer therapy
    Aisha Aziz, Urushi Rehman, Afsana Sheikh, Mohammed A. S. Abourehab, Prashant Kesharwani · 2022 · Journal of Biomaterials Science Polymer Edition
  60. Hydrogen donors and acceptors and basic amino acids jointly contribute to carcinogenesis
    Man Tang, Yanchao Zhou, Yiqi Li, Juntong Zou, Bei-Cheng Yang, Li Cai, Xuelan Zhang, Qiuyun Liu · 2016 · Medical Hypotheses
  61. Nanoscale delivery platforms for RNA therapeutics: Challenges and the current state of the art
    Luke H. Rhym, Daniel G. Anderson · 2022 · Med
  62. Bioreducible, hydrolytically degradable and targeting polymers for gene delivery
    Ihsan Ullah, Khan Muhammad, Mary Akpanyung, Abdelilah Nejjari, Agnaldo Luis Neve, Jintang Guo, Yakai Feng, Changcan Shi · 2017 · Journal of Materials Chemistry B
  63. Gene Therapy for Liver Cancers: Current Status from Basic to Clinics
    Kenya Kamimura, Takeshi Yokoo, Hiroyuki Abé, Shuji Terai · 2019 · Cancers
  64. Applications of CRISPR as a potential therapeutic
    Ritika Luthra, Simran Preet Kaur, Kriti Bhandari · 2021 · Life Sciences
  65. Efficient Delivery of mRNA Using Crosslinked Nucleic Acid Nanogel as a Carrier
    Xiangang Huang, Ru Zheng, Fei Ding, Jiapei Yang, Miao Xie, Xinlong Liu, Jing Li, Jing Chun Feng, Xinyuan Zhu, Chuan Zhang · 2020 · ACS Materials Letters
  66. Calcium-based nanomaterials and their interrelation with chitosan: optimization for pCRISPR delivery
    Navid Rabiee, Mojtaba Bagherzadeh, Amir Mohammad Ghadiri, Mahsa Kiani, Sepideh Ahmadi, Vahid Jajarmi, Yousef Fatahi, Abdullah Aldhaher, Mohammadreza Tahriri, Thomas Jay Webster et al. · 2021 · Journal of nanostructure in chemistry
  67. Treatment of a metabolic liver disease in mice with a transient prime editing approach
    Tanja Rothgangl, András Tálas, Eleonora I. Ioannidi, Yanik Weber, Desirée Böck, Mai Matsushita, Elina Andrea Villiger, Lukas Schmidheini, Woohyun J Moon, Paulo J.C. Lin et al. · 2025 · Nature Biomedical Engineering
  68. Genome Editing of Monogenic Neuromuscular Diseases
    Chengzu Long, Leonela Amoasii, Rhonda Bassel‐Duby, Eric N. Olson · 2016 · JAMA Neurology
  69. The CRISPR/Cas9 system: Their delivery, in vivo and ex vivo applications and clinical development by startups
    Minjung Song · 2017 · Biotechnology Progress
  70. CRISPR/Cas9: at the cutting edge of hepatology
    Francis P. Pankowicz, Kelsey E. Jarrett, William R. Lagor, Karl‐Dimiter Bissig · 2017 · Gut
  71. Development of Cationic Quaternary Ammonium Sulfonamide Amino Lipids for Nucleic Acid Delivery
    Jason B. Miller, Petra Kós, Victor Tieu, Kejin Zhou, Daniel J. Siegwart · 2017 · ACS Applied Materials & Interfaces
  72. Personalised genome editing – The future for corneal dystrophies
    Tara Moore, Kathleen A. Christie, John Marshall, M. Andrew Nesbit · 2018 · Progress in Retinal and Eye Research
  73. Cas9-mediated allelic exchange repairs compound heterozygous recessive mutations in mice
    Dan Wang, Jia Li, Chun‐Qing Song, Karen Tran, Haiwei Mou, Pei‐Hsuan Wu, Phillip W.L. Tai, Craig A. Mendonca, Lingzhi Ren, Blake Y. Wang et al. · 2018 · Nature Biotechnology
  74. Optimized nanoparticle-mediated delivery of CRISPR-Cas9 system for B cell intervention
    Min Li, Ya-Nan Fan, Zhiyao Chen, Ying‐Li Luo, Yucai Wang, Zhe‐Xiong Lian, Cong‐Fei Xu, Jun Wang · 2018 · Nano Research
  75. Single AAV-mediated mutation replacement genome editing in limited number of photoreceptors restores vision in mice
    Koji M. Nishiguchi, Kosuke Fujita, Fuyuki Miya, Shota Katayama, Toru Nakazawa · 2020 · Nature Communications
  76. Lipid‐Modified Aminoglycosides for mRNA Delivery to the Liver
    Xueliang Yu, Shuai Liu, Qiang Cheng, Tuo Wei, Sang M. Lee, Di Zhang, Daniel J. Siegwart · 2020 · Advanced Healthcare Materials
  77. Light-responsive charge-reversal nanovector for high-efficiency in vivo CRISPR/Cas9 gene editing with controllable location and time
    Yunxia Wu, Judun Zheng, Qin Zeng, Tao Zhang, Da Xing · 2020 · Nano Research
  78. Translating CRISPR-Cas Therapeutics: Approaches and Challenges
    Lavina Sierra Tay, Nathan D. Palmer, Rebecca Panwala, Wei Leong Chew, Prashant Mali · 2020 · The CRISPR Journal
  79. Enhancing Specificity, Precision, Accessibility, Flexibility, and Safety to Overcome Traditional CRISPR/Cas Editing Challenges and Shape Future Innovations
    Muna Alariqi, Mohamed Ramadan, Lu Yu, Fengjiao Hui, Amjad Hussain, Xiaofeng Zhou, Yu Yu, Xianlong Zhang, Shuangxia Jin · 2025 · Advanced Science
  80. Current application of CRISPR/Cas9 gene-editing technique to eradication of HIV/AIDS
    Z Huang, Asahi Tomitaka, Andrea Raymond, Madhavan Nair · 2017 · Gene Therapy
  81. Comparative analysis of chimeric ZFP-, TALE- and Cas9-piggyBac transposases for integration into a single locus in human cells
    Wentian Luo, Daniel L. Galvan, Lauren Elizabeth Woodard, Dan C. Dorset, Shawn A. Levy, Matthew H. Wilson · 2017 · Nucleic Acids Research
  82. Fah Knockout Animals as Models for Therapeutic Liver Repopulation
    Markus Grompe · 2017 · Advances in experimental medicine and biology
  83. The rapidly evolving state of gene therapy
    Alisha M. Gruntman, Terence R. Flotte · 2018 · The FASEB Journal
  84. Ex Vivo/In vivo Gene Editing in Hepatocytes Using “All-in-One” CRISPR-Adeno-Associated Virus Vectors with a Self-Linearizing Repair Template
    Simon Alexander Krooss, Zhen Dai, Florian Schmidt, Alice Rovai, Julia Fakhiri, Akshay Dhingra, Qinggong Yuan, Taihua Yang, Asha Balakrishnan, Lars Steinbrück et al. · 2019 · iScience
  85. Cancer Nanomedicines in an Evolving Oncology Landscape
    Peng Guo, Jing Huang, Marsha A. Moses · 2020 · Trends in Pharmacological Sciences
  86. ZnAl nano layered double hydroxides for dual functional CRISPR/Cas9 delivery and enhanced green fluorescence protein biosensor
    Navid Rabiee, Mojtaba Bagherzadeh, Amir Mohammad Ghadiri, Ghazal Salehi, Yousef Fatahi, Rassoul Dinarvand · 2020 · Scientific Reports
  87. GUIDEseq: a bioconductor package to analyze GUIDE-Seq datasets for CRISPR-Cas nucleases
    Lihua Julie Zhu, Michael Lawrence, Ankit Gupta, Hervé Pagès, Alper Küçükural, Manuel G. Garber, Scot A. Wolfe · 2017 · BMC Genomics
  88. Design of synthetic materials for intracellular delivery of RNAs: From siRNA-mediated gene silencing to CRISPR/Cas gene editing
    Jason B. Miller, Daniel J. Siegwart · 2018 · Nano Research
  89. Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting
    Yu Sakurai, Wataru Mizumura, Manami Murata, Tomoya Hada, Shoshiro Yamamoto, Kenichiro Ito, Kazuhiro Iwasaki, Takayuki Katoh, Yuki Goto, Asako Takagi et al. · 2017 · Molecular Pharmaceutics
  90. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1
    Caitlin J. VanLith, Rebekah M. Guthman, Clara T. Nicolas, Kari L. Allen, Zeji Du, Dong Jin Joo, Scott L. Nyberg, Joseph B. Lillegard, Raymond Hickey · 2018 · Human Gene Therapy
  91. CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
    Xiaoping Zhang, Xu Chen, Shijuan Gao, Ping Li, Yu Kong, Tiantian Li, Yulin Li, Fu‐Jian Xu, Jie Du · 2019 · Advanced Science
  92. Dendrimers as Drug Nanocarriers: The Future of Gene Therapy and Targeted Therapies in Cancer
    Ida Franiak Pietryga, Barbara Ziemba, Bradley T. Messmer, Dorota Skowronska‐Krawczyk · 2018 · InTech eBooks
  93. Reduction of Kaposi’s Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene
    For Yue Tso, John T. West, Charles A. Wood · 2019 · Journal of Virology
  94. Progress and challenges in development of new therapies for urea cycle disorders
    Leandro R. Soria, Nicholas Ah Mew, Nicola Brunetti‐Pierri · 2019 · Human Molecular Genetics
  95. CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy
    Dennis Huang, Matthew Miller, Bhaargavi Ashok, Samagra Jain, Nicholas A. Peppas · 2020 · Advanced Drug Delivery Reviews
  96. Genome Editing
    Kiran Musunuru · 2017 · Journal of the American College of Cardiology
  97. CRISPR/Cas9-Mediated Gene Correction in Newborn Rabbits with Hereditary Tyrosinemia Type I
    Nan Li, Shixue Gou, Jiaowei Wang, Quanjun Zhang, Xingyun Huang, Jingke Xie, Li Li, Qin Jin, Zhen Ouyang, Fangbing Chen et al. · 2020 · Molecular Therapy
  98. Amelioration of an Inherited Metabolic Liver Disease through Creation of a De Novo Start Codon by Cytidine Base Editing
    Lei Yang, Liren Wang, Yanan Huo, Xi Chen, Shuming Yin, Yaqiang Hu, Xiaohui Zhang, Rui Zheng, Hongquan Geng, Honghui Han et al. · 2020 · Molecular Therapy
  99. The Benefits of Going Small: Nanostructures for Mammalian Cell Transfection
    Andy Kah Ping Tay · 2020 · ACS Nano
  100. CRISPR/Cas-Dependent and Nuclease-Free In Vivo Therapeutic Gene Editing
    Ishani Dasgupta, Terence R. Flotte, Allison M. Keeler · 2021 · Human Gene Therapy